Adenosine deaminase complexing protein (ADCP): a transformation sensitive protein with potentials of a cancer marker.
Several observations by independent investigators in the past have indicated that adenosine deaminase complexing protein (ADCP), present in considerable quantities in certain human tissues, was absent or decreased in the cancers originated from them. During the present study, electrophoretic analysis of adenosine deaminase (ADA) isozymes and radioimmunoassay for ADCP in the primary fibroblasts and the transformed as well as certain tumor derived cell lines have demonstrated that ADCP present in large quantities in the primary cells was absent or nearly absent in the transformed or tumor-derived cell lines. Though the mechanisms involved are not yet clear, the above observations indicate that ADCP has the potentials of a useful marker in the studies on transformed cells and cancer tissues.
D000243:Adenosine Deaminase / Q000032:analysis*; D002352:Carrier Proteins / Q000032:analysis*; D002460:Cell Line; D002471:Cell Transformation, Neoplastic; D004796:Clinical Enzyme Tests; D018819:Dipeptidyl Peptidase 4; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis*; D009700:Nucleoside Deaminases / Q000032:analysis*; D012867:Skin / Q000201:enzymology
D002352:Carrier Proteins; D018819:Dipeptidyl Peptidase 4; D009700:Nucleoside Deaminases; D000243:Adenosine Deaminase